vTv Therapeutics Announces Screening of First Patient in CATT1 Pivotal Trial Evaluating Cadisegliatin for Type 1 Diabetes

Stock Information for vTv Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.